BIOTHERANOSTICS
Biotheranostics is a commercial-stage molecular diagnostics company that develops and provides diagnostic, prognostic, and predictive tests that support physicians in the treatment of cancer patients. Biotheranostics is a leader in the development of evidence-based biomarkers to address unmet medical needs, and the Company has set the foundation for rapid growth. The company is based in San Diego, California, and offers testing services through its CLIA-certified, CAP-accredited laboratory that is directly licensed or otherwise authorized to perform testing in all 50 states.
BIOTHERANOSTICS
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
1996-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.biotheranostics.com
Total Employee:
11+
Status:
Active
Contact:
(877)886-6739
Email Addresses:
info@biotheranostics.comwendy.johnson@biotheranostics.com
lisa.whitmyer@biotheranostics.com
Total Funding:
32 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Mobile Non Scaleable Content Nginx Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS
Similar Organizations
Cardiac Clinical Management System
CCMS’s core technology is a diagnostic algorithm that helps physicians identify patients with leg pain.
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Signal Genetics
Signal Genetics, Inc., is a commercial-stage, molecular diagnostics company providing innovative diagnostic services.
Current Advisors List
Board_member
2016-07-01
Current Employees Featured
Don Hardison President & CEO @ Biotheranostics
President & CEO
2017-02-01
Investors List
HealthQuest Capital
HealthQuest Capital investment in Venture Round - Biotheranostics
Evidity Health Capital
Evidity Health Capital investment in Venture Round - Biotheranostics
MVM Life Science Partners
MVM Life Science Partners investment in Venture Round - Biotheranostics
Official Site Inspections
http://www.biotheranostics.com
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Biotheranostics"
Biotheranostics - Crunchbase Company Profile & Funding
Biotheranostics is a leader in the development of evidence-based biomarkers to address unmet medical needs, and the Company has set the foundation for rapid growth. The company is based in San Diego, California, and offers testing …See details»
Hologic to Acquire Biotheranostics, Leader in Molecular Tests for ...
Jan 5, 2021 – Transaction Accelerates Hologic’s Entry into Oncology Growth Market, Provides New Lab Capabilities – – Hologic’s Commercial Resources, Expertise in Molecular Automation …See details»
Hologic to Acquire Biotheranostics, Leader in …
Jan 5, 2021 Biotheranostics is a leader in the development of evidence-based biomarkers to address unmet medical needs, and the company has set the foundation for rapid growth. For more information, visit ...See details»
Hologic, Inc. - Hologic Completes Acquisition of Biotheranostics ...
Feb 22, 2021 - Breast Cancer Index ™ Added to National Comprehensive Cancer Network Guidelines to Predict Benefit from Extended Endocrine Therapy - Hologic, Inc. (Nasdaq: …See details»
Hologic Completes Acquisition of Biotheranostics, Enters Growing ...
“We are thrilled that the Biotheranostics team will become part of Hologic’s diagnostic business. Hologic’s leadership in women’s health and molecular automation will accelerate access for …See details»
Biotheranostics, Inc., A Hologic Company | LinkedIn
Biotheranostics, Inc. has been acquired by Hologic. Hologic is an innovative medical technology company whose purpose is to enable healthier lives everywhere, every day.See details»
Hologic Completes Acquisition of Biotheranostics, …
Feb 22, 2021 Biotheranostics also developed and markets the CancerTYPE ID test, which provides a molecular diagnosis for patients with uncertain or unknown cancers. In advanced cancer that has metastasized, it ...See details»
Hologic to Acquire Biotheranostics, a Leader in Molecular Tests for ...
Jan 5, 2021 Hologic announced today that it has agreed to acquire Biotheranostics, a privately held, commercial-stage company that provides molecular diagnostic tests for breast and …See details»
Hologic announces acquisition of Biotheranostics - MVM Partners …
Jan 5, 2021 Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial-stage company …See details»
Biotheranostics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Biotheranostics, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Biotheranostics Company Profile 2024: Valuation, Investors
Biotheranostics General Information Description. Developer of commercial-stage molecular diagnostics intended to guide cancer treatment. The company develops and commercializes …See details»
Hologic Completes Acquisition of Biotheranostics
Feb 23, 2021 Biotheranostics also developed and markets the CancerType ID test, which provides a molecular diagnosis for patients with uncertain or unknown cancers. ... Genomenon …See details»
Hologic to Acquire Biotheranostics, Leader in Molecular Tests for ...
Jan 5, 2021 Hologic, Inc., a global leader in women's health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial-stage company that provides …See details»
Biotheranostics Company Profile - Office Locations, Competitors
Biotheranostics is a molecular diagnostics company that develops and provides diagnostic, prognostic, and predictive tests that helps physicians in the treatment of cancer patients. It …See details»
Hologic's $230M Biotheranostics buy its 2nd M&A deal of 2021
Jan 6, 2021 Hologic announced late Tuesday its acquisition of Biotheranostics for $230 million, marking the second tuck-in for the medical device maker less than a week into 2021. The deal …See details»
Working at bioTHERANOSTICS Corporation: 7 Reviews - Indeed
Reviews from bioTHERANOSTICS Corporation employees about bioTHERANOSTICS Corporation culture, salaries, benefits, work-life balance, management, job security, and more. …See details»
Biotheranostics Announces Inclusion of Breast Cancer Index in the ...
Jan 19, 2021 Biotheranostics, Inc., is a leading healthcare provider in the oncology field assisting physicians in the treatment of cancer patients. ... It also allows our organization to realize its …See details»
bioTheranostics Announces Commercial Availability of Expanded …
For bioTheranostics: Wendy Johnson Tel: 1 858 587 5887 Wendy.Johnson@biotheranostics.com. Michele Parisi Tel: 1 925 864 5028 mparisi@biocommnetwork.com. For bioMérieux: Koren …See details»
Biotheranostics Announces Inclusion of Breast Cancer Index
Jan 19, 2021 Contact Data Lisa Whitmyer Biotheranostics, Inc. 216-513-7808 lisa.whitmyer@biotheranostics.comSee details»